PLx Pharma (PLXP) Short Interest Ratio & Short Volume

Short interest is the volume of PLx Pharma shares that have been sold short but have not yet been closed out or covered. As of March 31st, investors have sold 246,200 shares of PLXP short. Learn More on PLx Pharma's current short interest.

PLx Pharma saw a increase in short interest during the month of March. As of March 31st, there was short interest totaling 246,200 shares, an increase of 81.7% from the previous total of 135,500 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Here is how the short interest of companies in the sector of "medical" compare to PLx Pharma: Comera Life Sciences Holdings, Inc. (2.38%), China SXT Pharmaceuticals, Inc. (11.61%), Aptevo Therapeutics Inc. (9.10%), Aditxt, Inc. (10.83%), SciSparc Ltd. (21.38%), Evelo Biosciences, Inc. (2.11%), Sunshine Biopharma, Inc. (7.32%), GRI Bio, Inc. (0.61%), Biodexa Pharmaceuticals Plc (14.70%), Panbela Therapeutics, Inc. (2.36%),

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($4.66 billion), TC Energy Co. ($4.13 billion), Occidental Petroleum Co. ($3.04 billion), Moderna, Inc. ($2.63 billion), Coinbase Global, Inc. ($2.51 billion), T. Rowe Price Group, Inc. ($2.29 billion), Paramount Global ($2.26 billion), Verisk Analytics, Inc. ($2.19 billion), Etsy, Inc. ($1.84 billion), and Voya Financial, Inc. ($1.67 billion). View all of the most shorted stocks.

Short selling PLXP is an investing strategy that aims to generate trading profit from PLx Pharma as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for PLx Pharma occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of PLXP, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including PLXP, twice per month. The most recent reporting period available is March, 31 2023.